IIT Jodhpur led team develops fluorescent probe for diagnosis of Alzheimer’s disease
Vagisha Kaushik | September 1, 2022 | 06:30 PM IST | 2 mins read
IIT Jodhpur, IIT Kharagpur and CSIR- Indian Institute of Chemical Biology have prepared an inexpensive alternative to diagnose Alzheimer’s.
NEW DELHI : A multi-institutional team led by the Indian Institute of Technology (IIT) Jodhpur has developed an efficient fluorescent molecular probe that can be used in the diagnosis of Alzheimer’s disease. The research has been carried out in collaboration with IIT Kharagpur, and Council of Scientific and Industrial Research - Indian Institute of Chemical Biology (CSIR-IICB) Kolkata.
“The diagnosis of Alzheimer’s disease involves assessment of cognitive functions, the observation of brain size and structure through SPECT, PET and MRI scans, and the detection of amyloid plaques. Amyloid plaques are detected by extracting the brain fluid (cerebro-spinal fluid) through a spinal tap, or by PET Scans. Although both methods are reliable, they are invasive and expensive,” said an official statement from IIT Jodhpur.
Also Read | IIT Delhi Fee Hike: MTech students protest against '100% fee hike', demand affordable education
Explaining how the probe works, the institute said that fluorescent probe diagnosis involves injecting a fluorescent chemical that specifically attaches itself to the amyloid plaque and assessing the change in fluorescent properties using an appropriate detector. The fluorescent chemical, in addition to being able to specifically and selectively attach to Aβ aggregates, must also be able to cross the blood-brain barrier to reach the brain. There must also be a change in its fluorescent properties – colour and intensity - when it attaches to Aβ aggregates.
The IIT researchers have successfully designed and developed a series of fluorescent molecules that can selectively bind to Aβ aggregates. All these molecules were seen to emit fluorescence in one colour when unbound, and the emission colour shifted towards red in the visible light (rainbow – violet indigo blue green yellow orange red) spectrum with a concomitant increase in fluorescence intensity.
Also Read | ‘Indian Institute of Upper Caste’: 9 IIMs violated PhD reservation norms, says IIT Bombay group
One of the molecules was stable in biological fluids and could easily traverse the blood-brain barrier. It was also selective to Aβ aggregates in the presence of competing biomolecules. Therefore, the probe found by the research team will provide a non-invasive and inexpensive reliable alternative to a spinal tap or PET Scan methods Alzheimer’s diagnosis.
Highlighting his research, Surajit Ghosh, Professor, Department of Bioscience and Bioengineering and Dean, Research and Development, IIT Jodhpur said, “Optical imaging systems that use fluorescent or colour-based chemicals to target tissues and molecules of interest are considered better diagnostic techniques in the biomedical area.”
Follow us for the latest education news on colleges and universities, admission, courses, exams, research, education policies, study abroad and more..
To get in touch, write to us at news@careers360.com.
Next Story
]Featured News
]- IIT Ropar’s ANNAM.AI is ‘green intelligence in action’ and future of agriculture technology: Project director
- Delhi HC halts recruitment at DU’s St. Stephen’s College after ad hoc teachers allege irregularities
- IIT Kharagpur tackling mental health crisis with ‘mothers’, mentors and an app: First student wellbeing dean
- NEET was far from fair even before paper-leak controversies
- Same Exam, Old Nightmare: NEET 2026 cancelled, paper-leak probe, NTA reform, re-neet – the story so far
- IIT Jodhpur’s Hindi BTech is breaking the English-only mould, model for others to follow: Director
- ‘Part of culture’? IIT Ropar PhD scholars say fear keeps harassment cases buried, rarely reach ICC
- Number of student suicides rises 80% in 10 years, 8.5% of total: NCRB report
- ANRF PAIR Programme gives Rs 100 crore to just 7 hub-spoke networks, rest get Rs 2 crore grants
- Pharmacy Council of India revamps B Pharma syllabus with AI, hospital training; rollout from 2026-27 session